Ownership history in Freestone Grove Partners LP · 4 quarters on record
This page tracks every 13F SEC filing in which Freestone Grove Partners LP reported a position in ELANCO ANIMAL HEALTH INC (ELAN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 3,841,422 | -9,628 | -0.3% | 0.58% | $77.4M | $20.14 |
| 2025 Q2 | ADDED | 3,851,050 | +643,715 | +20.1% | 0.42% | $55.0M | $14.28 |
| 2025 Q1 | ADDED | 3,207,335 | +1,523,145 | +90.4% | 0.35% | $33.7M | $10.50 |
| 2024 Q4 | INITIATED | 1,684,190 | — | — | 0.25% | $20.4M | $12.11 |
As of 2025 Q4 — sorted by position size